-
1تقرير
المصدر: PRE-Investigation of Serial Studies to Predict Your Therapeutic Response With Imaging And moLecular Analysis: A Phase I/Ib Platform Trial
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05868226Test
-
2تقرير
المؤلفون: Byondis B.V.
المصدر: ISPY-P1.01: Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer: A Phase I/Ib Trial
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04602117Test
-
3تقرير
المصدر: A Phase 1/2a, Open-Label, Multi-Center Study Evaluating the Safety and Anti-Tumor Activity of Ex Vivo Expanded, Autologous Natural Killer Cells (SNK01) in Combination With Trastuzumab or Cetuximab in Subjects With Advanced/Metastatic HER2- or EGFR-Expressing Cancers
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04464967Test
